News
First patient dosed in ELEVATE-44-201 with data from first patient cohort anticipated in H1 2026 -- -- Initiated ELEVATE-45-201 and on track to dose the first patient in Q3 2025 -- -- Multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback